|
|
||||||||
1 Department of Veterans Affairs Sleep Disorders Center-Northport, Division of Pulmonary/Critical Care Medicine, Department of Medicine, State University of New York-Stony Brook, Stony Brook, New York 11794; and 2 The Johns Hopkins Sleep Disorders Center, Hopkins Bayview Campus, Baltimore, Maryland 21224
| |
ABSTRACT |
|---|
|
|
|---|
The upper airway is a complicated
structure that is usually widely patent during inspiration. However, on
inspiration during certain physiological and pathophysiological states,
the nares, pharynx, and larynx may collapse. Collapse at these
locations occurs when the transmural pressure (Ptm) at a flow-limiting
site (FLS) falls below a critical level (Ptm'). On airway
collapse, inspiratory airflow is limited to a maximal level
(
Imax)
determined by (
Ptm')/Rus, where Rus is the resistance
upstream to the FLS. The airflow dynamics of the upper airway are
affected by the activity of its associated muscles. In this study, we
examine the modulation of
Imax
by muscle activity in the nasal airway under conditions of inspiratory
airflow limitation. Each of six subjects performed sniffs through one
patent nostril (pretreated with an alpha agonist) while flaring the
nostril at varying levels of dilator muscle (alae nasi) EMG activity
(EMGan). For each sniff, we located the nasal FLS with an airway
catheter and determined
Imax,
Ptm', and Rus. Activation of the alae nasi from the lowest to the
highest values of EMGan increased
Imax
from 422 ± 156 to 753 ± 291 ml/s (P < 0.01) and decreased
Ptm' from
3.6 ± 3.0 to
6.0 ± 4.7 cmH2O (P < 0.05). Activation of the alae
nasi had no consistent effect on Rus.
Imax
was positively correlated with EMGan, and Ptm' was negatively
correlated with EMGan in all subjects. Our findings demonstrate that
alae nasi activation increases
Imax
through the nasal airway by decreasing airway collapsibility.
Starling resistor; airway collapsibility; upper airway
| |
INTRODUCTION |
|---|
|
|
|---|
THE UPPER AIRWAY is a complicated structure exhibiting
a range of behaviors during breathing. Normally, the upper airway is widely patent throughout inspiration. During certain physiological and
pathophysiological conditions, however, the upper airway collapses during inspiration. Collapse of the upper airway may completely or
partially obstruct inspiratory airflow
(
I).
Obstructive sleep apnea represents complete
I obstruction
at the nasopharynx, oropharynx, or hypopharynx (19, 23, 25, 36).
Sniffing (2, 3, 14, 15, 24), snoring (4, 12), and stridor (6, 11, 20)
represent partial
I obstruction
at the nares, pharynx, larynx, and extrathoracic trachea. Whenever
partial
I obstruction occurs, collapse of a flow-limiting site (FLS) limits airflow to a maximal level
(
Imax)
(13, 14). Under these circumstances,
I does not
exceed
Imax
as inspiratory effort increases progressively. Thus, although the upper
airway FLS may vary in location, the phenomena of collapse and
I limitation are similar throughout the upper airway.
The airflow dynamics of the upper airway are affected markedly by the
activity of its associated muscles. It is now recognized that upper
airway muscles act in at least two ways. First, their contraction may
affect airway caliber by dilating or constricting the airway (16, 17,
21, 31, 37, 38, 40, 41). Second, their contraction may reduce
collapsibility by stiffening the airway (16, 17, 21, 34).
Hypothetically, either action may affect the level of
Imax
during upper airway collapse and airflow limitation. However, it is
unclear how upper airway muscle activity actually modulates
Imax
(1, 27).
Methods have been developed to determine the mechanism for alterations
in
Imax
(14, 34). It has been established that the level of maximal flow
through biological tubes is determined by two physiological parameters.
The first is the transmural pressure (Ptm) at which the FLS collapses
[the critical Ptm (Ptm')], which is an index of
airway collapsibility. The second is the airway resistance upstream to
the FLS (Rus), which reflects the caliber of the upstream airway
segment. Thus, study of airflow dynamics during
I limitation
can help us to determine whether changes in
Imax
are related to changes in airway caliber or collapsibility.
In this study, we examined the modulation of
Imax
by muscle activity under conditions of
I limitation.
The study of maximal
I
dynamics requires the simultaneous measurement of muscle activity at
the onset of
I
limitation,
Imax,
and the Ptm' of the FLS. Such a study is most easily performed in
the nasal airway because it is easy to instrument, demonstrates
I limitation,
and contains the dilator naris portion of the nasalis muscle (the alae
nasi) that is under voluntary control. In a recent study, we used a nasal catheter to locate the FLS of the nasal airway and to
characterize nasal
I dynamics
under conditions of flow limitation (14). To examine how upper airway
muscles influence
Imax,
we used the catheter method to study the effect of varying alae nasi
activity on
Imax
and its determinants (Ptm' and Rus).
| |
METHODS |
|---|
|
|
|---|
Subjects. For this study, we selected only subjects who were able to voluntarily flare their nasal alae. Our six subjects (five men and one woman) were all Caucasian health care workers. One subject had a history of allergic rhinitis, but none of the subjects had a disorder of the lower respiratory tract. Each subject was free of upper respiratory tract symptoms on the day of study. The methods used were approved by the Research and Development Committee of the DVA Medical Center-Northport, and informed consent was obtained from the subjects.
Experimental apparatus.
Our methods for studying maximal nasal airflow dynamics with the use of
a nasal catheter have been previously presented in detail (14).
Briefly, a nasal mask was connected in series with a pneumotachograph
(model 3813, Hans Rudolph, Kansas City, MO) measuring
I (Fig.
1). Mask pressure (Pmask) was measured with a pressure transducer (model 23ID, Spectramed, Oxnard CA) from a
pressure port in the mask. Nasopharyngeal pressure (Pnp), a pressure
downstream to the collapsible segment of the nasal airway, was measured
by using anterior rhinometry through the left nostril.
|
Imax
(14). To measure PFLS, we placed
the lateral port of a pressure catheter (1.9 mm OD) immediately
downstream to the FLS (Fig. 1) (14). We placed the lateral port of a
second pressure catheter 2 mm distal to the first (Fig. 1) to detect a
shift of the FLS with alae nasi activation. If the Ptm' of the
FLS at the nasal opening decreased sufficiently with alae nasi
activation, then another more collapsible site might become the FLS
(Fig. 2). The surface electromyogram (EMG)
activity of the alae nasi was monitored by using two electrodes fixed
to the left ala and a ground fixed to the forehead. To obtain the
moving average EMG (EMGan), the EMG signal was band-pass filtered
(10-1,000 Hz), amplified, full-wave rectified, and passed through
a low-pass moving-average filter with a time constant of 200 ms (model
MA821, CWE, Ardmore, PA).
|
I, Pmask, PFLS, and nasopharyngeal
pressure (Pnp) simultaneously on a polygraph recorder (model 78, Grass
Instruments, Quincy, MA). A microcomputer was used to digitize all the
physiological signals with an acquisition frequency of 500 Hz and to
store them for subsequent analysis (Easyest LX, Keithley ASYST,
Taunton, MA).
Because the determination of the Ptm' of the nasal FLS depends on
the accurate measurement of rapidly changing signals, the pressure and
flow signals obtained during several sniffs were analyzed by fast
Fourier transform. We determined that >99% of the signal power was
<5 Hz. The frequency-response system characteristics of each
catheter- transducer-amplifier combination were also examined, and the
amplitude of each was >95% at 10 Hz.
Experimental protocol.
Each of our subjects performed a series of sniffs while varying the
level of alae nasi activity by voluntarily flaring the nasal alae.
Subjects controlled the level of alar flaring by viewing the EMGan on
the polygraph tracing (Fig. 3). We
randomized the order of EMG activity levels and asked subjects to
replicate each level of activation for three consecutive sniffs. Each
subject was allowed to coordinate alae nasi activation with inspiratory effort comfortably. Reproducibility of the maximal nasal
I dynamics was
facilitated by spraying subjects' nostrils with a long-acting nasal
decongestant (0.05% oxymetazoline hydrochloride).
|
Data analysis.
For each sniff, we determined the three parameters characterizing
maximal nasal
I:
Imax,
Ptm', and Rus. To accomplish this, we identified the moment
Imax
was attained and obtained the corresponding values of EMGan
(EMGan'), PFLS
(PFLS'), and Pmask
(Pmask'; Fig. 4). We then fitted the
values into the following equations
|
(1) |
|
(2) |
|
I dynamics, we
plotted and regressed each subject's values of
Imax,
Ptm', and Rus on the corresponding values of EMGan' by
using a least squares linear regression. We quantified the strength of
the relationships with the correlation coefficients. For each subject,
we also calculated the mean values for
Imax, Ptm', and Rus at the lowest and highest values of EMGan'
observed (5 or 6 values for each mean). We compared high and low values for the group of subjects by using a paired
t-test.
| |
RESULTS |
|---|
|
|
|---|
All six subjects demonstrated a FLS at the nasal opening. Voluntary
alar flaring produced values of EMGan' that ranged from 1.3 ± 1.6 (range, 0-3.8%) to 72.3 ± 11.0% (range,
55.2-81.6%) of maximal EMG activity. Although all subjects were
able to match their maximal EMG activity throughout the study, they
were unable to synchronize
Imax
with values of EMGan' above 82% of maximal activity. Alae nasi
activation did not cause downstream migration of the FLS in any
subject.
The effects of alae nasi activity on
Imax,
Ptm' and Rus are illustrated in Fig.
5 and Table 1.
Alae nasi activity significantly increased
Imax
and decreased Ptm' (Table 1). All subjects demonstrated a
significant correlation between EMGan' and both
Imax
and Ptm' (Fig. 5).
|
|
Alae nasi activity did not consistently affect Rus (Table 1). Figure 5 demonstrates a negative correlation between EMGan' and Rus for two subjects (subjects 3 and 6), a positive correlation for two subjects (subjects 1 and 2), and no correlation for two subjects (subjects 4 and 5).
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we examined how an upper airway muscle affects
Imax.
We accomplished this by studying the effect of varying alae nasi
activity on nasal
Imax.
Our methods allowed us to attribute any increase in
Imax
to a decrease in either Ptm' or Rus. Patients sniffed through one
nostril while flaring the ala with varying levels of effort. Airflow
dynamics were studied with a nasal catheter at the onset of
I limitation
(
Imax). In all subjects, high levels of alae nasi activity were associated with
an increased
Imax
and a decreased Ptm' of the nasal FLS. We also found that a
decrease in Rus in two subjects contributed to observed increases in
Imax.
Moreover, the nasal FLS remained at the nasal opening over the range of
EMG activity observed. We conclude from these findings that alae nasi
activity increased
Imax
in one of two ways (Eq. 2). First,
decreases in the Ptm' of the nasal FLS in each subject caused an
increase in
Imax. Second, decreases in Rus in some subjects also increased
Imax.
Our method for assessing the response of flow dynamics to ala nasi
activity depends on establishing the precise location of the nasal FLS.
We accomplished this by locating the point in the airway at which the
pressure in the nasal catheter continued to decrease beyond
Imax.
This methodology required a high level of precision. As demonstrated in
Fig. 4A
(PFLS), even a decrease of 0.2 cmH2O in catheter pressure lasting
50 ms after
Imax
is enough to establish a downstream location for the nasal catheter. Because we used a computer to record both the catheter pressure and the
I
every 2 ms, our methods had the necessary precision to identify the
nasal FLS. In previous use of this methodology (14) and in the present
study, we have demonstrated a FLS at the nasal opening in
10 of 11 unique subjects (1 subject participated in both studies). One
subject had a FLS located at a constriction at the junction of the
greater alar and lateral cartilages (the limen nasi). None of our
subjects had a FLS at the nasal valve. In contrast to our experience,
previous investigators (2, 3) have suggested that the nasal FLS is
usually deeper within the nasal airway at the nasal valve. We believe,
however, that the nasal FLS is usually located at the nasal opening and
that the methods previously employed (2, 3) lacked the precision to
accurately localize the nasal FLS. Therefore, because of the precision
of the catheter method, we have been able to establish the exact
location of the FLS, and have determined it to be at the nasal opening
for most of our subjects.
The catheter method allowed us to determine the effect of alae nasi
activity on airflow dynamics in the nose. We recognize, however, that
our methodology may have influenced our measurements of nasal function.
First, we placed two catheters in the nasal opening; this may have
narrowed the lumen and increased Rus. The combined area of the
catheters was 0.06 cm2, which
represented no more than 6% of the average area of the nasal opening
(>1.0 cm2; 18), suggesting that
the effect of these catheters on Rus was minimal. Second, we recognize
that the lower margin of the nasal mask funneled air into the nasal
opening (Fig. 1). This may have produced marked pressure losses caused
by convective acceleration and consequent increases in Rus. Whatever
the mechanism, increases in Rus would cause decreases in
Imax
at any level of Ptm' (Eq. 2).
Regardless of the magnitude of artifacts in our measurements of
Imax
and Rus, however, we would not expect any relationship between such
artifacts and alae nasi activity. Thus, we do not believe that the
catheter method affected the relationship between alae nasi activity
and our measurements of nasal airway function.
Once the FLS was located, we were able to characterize the function of
the FLS and upstream segment and to examine how their mechanical
properties modulated
Imax.
Specifically, we could apportion changes in
Imax
to alterations in either Ptm' or Rus. In our subjects, increases
in
Imax
with alae nasi activation were associated with decreases in Ptm'.
In contrast, the response of Rus to alae nasi activation was variable.
These findings suggest that increases in
Imax
were caused by decreases in Ptm' that reflected diminished
collapsibility of the FLS.
Although the Ptm' of the nasal FLS decreased consistently in all
subjects, the response of Rus to alae nasi activation was more
variable. This variable response occurred despite the known dilatory
effect of alae nasi activation on the nasal airway under conditions of
submaximal flow. The variability in the response of Rus can be
explained in two ways. First, it is likely that airflow turbulence
occurred at
Imax.
When airflow is turbulent, airway resistance increases with increasing
airflow. Consequently, Rus might have increased in individuals who
experienced a large increase in
Imax
with alae nasi activation. Conversely, Rus might have remained the same
or decreased in individuals in whom
Imax
did not increase greatly. Alternatively, the variable response of Rus
can be explained by the effect of alae nasi activation on Ptm'.
When the Ptm' of the FLS decreased, the segment upstream to the
FLS was exposed to more subatmospheric intraluminal pressures during a
vigorous sniff. This decrease in airway pressure may have narrowed the
upstream segment and increased its resistance. The greater the decrease
in Ptm' during alae nasi activation, the greater would be the
tendency for Rus to increase. Thus, an interaction between the dilating
effect of the alae nasi and changes in
Imax
and Ptm' could explain the variable response of Rus to alae nasi
activation. Regardless of the mechanism, our data indicate that
alterations in alae nasi activity have no consistent effect on Rus.
Previous investigators have differed on the mechanism by which alae nasi activity increases nasal airflow (1, 27). Strohl and associates (38) have demonstrated that, in humans breathing at submaximal flows, maximal alar flaring decreases nasal resistance by 29% compared with inspiration without alar flaring. This finding suggests that the major effect of the alae nasi is to dilate the nasal airway and decrease resistance under non-flow-limited conditions (at submaximal levels of airflow). Others (5, 8, 15) believe that the chief effect of the alae nasi is to stiffen the airway (decrease collapsibility), thereby preventing flow-limited conditions from developing.
Our findings suggest that the alae nasi may have increased airflow in
both of these ways. First, the alae nasi decreases resistance by
dilating the nasal airway (38), an effect that occurs consistently at
submaximal flows and variably at
Imax.
Second, our findings demonstrate that alae nasi activation decreased
the Ptm' of the nasal FLS. When the Ptm' falls, airway
pressure must become more negative for the FLS to collapse and limit
flow, and greater levels of nasal
I can be
accommodated (Eq. 2) as inspiratory
effort rises with exertion. Once nasal
I limitation
occurs, however, further increases in inspiratory effort no longer
generate any increase in nasal airflow, which can be supplemented only
by mouth breathing (26). Thus, nasal
I can increase
substantially when the alae nasi activate, because they prevent the
development of flow limitation with increasing ventilatory effort and
because they decrease nasal resistance over the entire range of
submaximal airflow.
In this study, we found the nasal valve to be located downstream to the
nasal FLS. Its downstream location should determine its role in
modulating airflow dynamics as follows. The nasal valve is the
narrowest site within the nasal airway and would be expected to
contribute significantly to the resistance of the downstream segment of
the airway (15). As the downstream resistance rises (e.g., during
congestion of the inferior turbinate), greater inspiratory effort is
required to reach
Imax.
The level of nasal
Imax,
however, should not be affected by changes in downstream resistance.
Nasal
Imax
can be affected only by the collapsibility of the FLS and by the nasal
Rus rather than the downstream resistance. Thus, increasing the
resistance at the nasal valve should decrease submaximal flows at any
level of inspiratory effort without affecting the nasal
Imax.
A model of the nasal airway in which changing the resistance at the
nasal valve does not affect
Imax
appears to conflict with previously reported observations. Several
studies (22, 28, 29) have demonstrated an increased peak nasal
Imax
after decongestion or surgical widening of the downstream nasal airway segment. Because the studies did not monitor the alae nasi, however, we
do not know the contribution of changes in alae nasi activity to their
findings. Decreasing nasal resistance (increasing submaximal airflow)
could increase alae nasi activity and increase nasal
Imax.
An increase in
Imax
delivered to the upper or lower airway has been demonstrated to
increase respiratory drive in humans (7, 10, 30). Such a mechanism can
be elucidated if alae nasi activity is examined at various levels of
downstream resistance.
Our findings in the nasal airway may also apply to the phenomena of
collapse and flow limitation in the pharynx and the larynx (4, 6, 11,
12, 19, 20, 25, 35, 36). Regardless of the site in the upper airway,
the principles of flow through a collapsible tube (the Starling
resistor model) have accounted for airflow dynamics under flow-limited
conditions. The Starling resistor is a passive model, with a FLS, an
upstream segment, and a downstream segment with fixed mechanical
properties. The upper airway, however, has a complex musculature with
activity that changes dynamically with respiration. It is well
recognized that the state of neuromuscular activity can dramatically
alter the flow dynamics across several potential sites of
I limitation throughout the upper airway. In our study, we have examined how flow
dynamics in one such site are influenced by voluntary activation of a
single muscle group. Our methods have allowed us to determine the
effect of this muscle group on
Imax
and to discern differences in its effect on the FLS and the upstream
segment. Using similar methods in the pharyngeal airway of an animal
model, investigators have demonstrated that pharyngeal dilator muscle
activity increases
Imax
by decreasing the collapsibility of the pharyngeal airway (32, 33).
Moreover, like the function of the alae nasi in the nasal airway, the
pharyngeal dilator muscles can increase
Imax
even as Rus increases (33). Thus, under conditions of flow limitation,
dilator muscles from different FLS in the upper airway increase airflow
by decreasing airway collapsibility regardless of their effect on
Rus. This mechanism of action can only be examined after
carefully locating the FLS and characterizing its function and that of
the upstream segment.
| |
ACKNOWLEDGEMENTS |
|---|
This research was supported by National Institutes of Health Grants RR-05736, HL-37379, and HL-50381.
| |
FOOTNOTES |
|---|
Address for reprint requests: A. R. Gold, Div. of Pulmonary/Critical Care Medicine (111D), DVA Medical Center, Northport, NY 11768.
Received 28 July 1997; accepted in final form 17 February 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Brancatisano, A.,
and
L. A. Engel.
Role of the upper airway in the control of respiratory flow and lung volume in humans.
In: Respiratory Function of the Upper Airway, edited by O. P. Mathew,
and G. Sant'Ambrogio. New York: Dekker, 1988, vol. 35, p. 472. (Lung Biol. Health Dis. Ser.)
2.
Bridger, G. P.
Physiology of the nasal valve.
Arch. Otolaryngol.
92:
543-553,
1970[Medline].
3.
Bridger, G. P.,
and
D. F. Proctor.
Maximum nasal inspiratory flow and nasal resistance.
Ann. Otol. Rhinol. Laryngol.
79:
481-486,
1970[Medline].
4.
Cistulli, P. A.,
and
C. E. Sullivan.
Pathophysiology of sleep apnea.
In: Sleep and Breathing, edited by N. A. Saunders,
and C. E. Sullivan. New York: Dekker, 1994, vol. 21, p. 407. (Lung Biol. Health Dis. Ser.)
5.
Cole, P.,
J. S. J. Haight,
L. Love,
and
D. Oprysk.
Dynamic components of nasal resistance.
Am. Rev. Respir. Dis.
132:
1229-1232,
1985[Medline].
6.
Cormier, Y.,
H. Kashima,
W. Summer,
and
H. Menkes.
Upper airways obstruction with bilateral vocal cord paralysis.
Chest
75:
423-427,
1979
7.
Corne, S.,
D. Gillespie,
D. Roberts,
and
M. Younes.
Effect of inspiratory flow rate on respiratory rate in intubated ventilated patients.
Am. J. Respir. Crit. Care Med.
156:
304-308,
1997
8.
Forsyth, R. D.,
P. Cole,
and
R. J. Shephard.
Exercise and nasal patency.
J. Appl. Physiol.
55:
860-865,
1983
9.
Fuller, D.,
J. Sullivan,
E. Essif,
K. Personius,
and
R. F. Fregosi.
Measurement of EMG-force relationship in a human upper airway muscle.
J. Appl. Physiol.
79:
270-278,
1995
10.
Georgopoulos, D.,
I. Mitrouska,
Z. Bshouty,
K. Webster,
N. R. Anthonisen,
and
M. Younes.
Effect of breathing route, temperature and volume of inspired gas and airway anesthesia on the response of respiratory output to varying inspiratory flow.
Am. J. Respir. Crit. Care Med.
153:
168-175,
1996[Abstract].
11.
Gibson, G. J.,
N. B. Pride,
and
D. W. Empey.
The role of inspiratory dynamic compression in upper airway obstruction.
Am. Rev. Respir. Dis.
108:
1352-1360,
1973[Medline].
12.
Gleadhill, I. C.,
A. R. Schwartz,
N. Schubert,
R. A. Wise,
S. Permutt,
and
P. L. Smith.
Upper airway collapsibility in snorers and in patients with obstructive sleep apnea.
Am. Rev. Respir. Dis.
143:
1300-1303,
1991[Medline].
13.
Gold, A. R.,
and
A. R. Schwartz.
The pharyngeal critical pressure: the whys and hows of using nasal continuous positive airway pressure diagnostically.
Chest
110:
1077-1088,
1996
14.
Gold, A. R.,
P. L. Smith,
and
A. R. Schwartz.
The study of maximal nasal inspiratory flow in humans.
J. Appl. Physiol.
81:
627-635,
1996
15.
Haight, J. S. J.,
and
P. Cole.
The site and function of the nasal valve.
Laryngoscope
93:
49-55,
1983[Medline].
16.
Hida, W.,
H. Kurosawa,
S. Okabe,
Y. Kikuchi,
J. Midorikawa,
Y. Chung,
T. Takishima,
and
K. Shirato.
Hypoglossal nerve stimulation affects the pressure-volume behavior of the upper airway.
Am. J. Respir. Crit. Care Med.
151:
455-460,
1995[Abstract].
17.
Hida, W.,
D. Wu,
H. Miki,
Y. Kikuchi,
H. Kurosawa,
H. Ogawa,
A. Mizusawa,
S. Ebihara,
M. Oikawa,
and
K. Shirato.
Pressure-volume relationships of upper airway in patients with obstructive sleep apnea (Abstract).
Am. J. Respir. Crit. Care Med.
153:
A690,
1996.
18.
Hilberg, O.,
A. C. Jackson,
D. L. Swift,
and
O. F. Pedersen.
Acoustic rhinometry: evaluation of nasal geometry by acoustic reflection.
J. Appl. Physiol.
66:
295-303,
1989
19.
Hudgel, D. W.
Variable site of airway narrowing among obstructive sleep apnea patients.
J. Appl. Physiol.
61:
1403-1409,
1986
20.
Kryger, M.,
F. Bode,
R. Antic,
and
N. Anthonisen.
Diagnosis of obstruction of the upper and central airways.
Am. J. Med.
61:
85-93,
1976[Medline].
21.
Kuna, S. T.
Effect of pharyngeal constrictor activation on the pharyngeal airway (Abstract).
Am. J. Respir. Crit. Care Med.
153:
A688,
1996.
22.
Larsen, K.,
and
S. Kristensen.
Peak flow nasal patency indices and self-assessment in septoplasty.
Clin. Otolaryngol.
15:
327-334,
1990[Medline].
23.
Leiter, J. C.,
S. L. Knuth,
and
D. Bartlett, Jr.
Dependence of pharyngeal resistance on genioglossal EMG activity, nasal resistance and airflow.
J. Appl. Physiol.
73:
584-590,
1992
24.
May, M.,
J. W. West,
and
K. H. Hinderer.
Nasal obstruction from facial palsy.
Arch. Otolaryngol.
103:
389-391,
1977[Abstract].
25.
Morrison, D. L.,
S. Launois,
S. Isono,
T. R. Feroah,
W. A. Whitelaw,
and
J. E. Remmers.
Pharyngeal narrowing and closing pressures in patients with obstructive sleep apnea.
Am. Rev. Respir. Dis.
148:
606-611,
1993[Medline].
26.
Niinimaa, V.,
P. Cole,
S. Mintz,
and
R. J. Shepard.
Oronasal distribution of respiratory airflow.
Respir. Physiol.
43:
69-75,
1981[Medline].
27.
Olson, L. G.,
J. M. Fouke,
P. L. Hoekje,
and
K. P. Strohl.
A biomechanical view of upper airway function.
In: Respiratory Function of the Upper Airway, edited by O. P. Mathew,
and G. Sant'Ambrogio. New York: Dekker, 1988, vol. 35, p. 365. (Lung Biol. Health Dis. Ser.)
28.
Pertuze, J.,
A. Watson,
and
N. B. Pride.
Maximum airflow through the nose in humans.
J. Appl. Physiol.
70:
1369-1376,
1991
29.
Phagoo, S. B.,
R. A. Watson,
and
N. B. Pride.
Use of nasal peak flow to assess nasal patency.
Allergy
52:
901-908,
1997[Medline].
30.
Puddy, A.,
and
M. Younes.
Effect of inspiratory flow rate on respiratory output in normal subjects.
Am. Rev. Respir. Dis.
146:
787-789,
1992[Medline].
31.
Schwartz, A. R.,
D. W. Eisele,
A. Hari,
R. Testerman,
D. Erickson,
and
P. L. Smith.
Electrical stimulation of the lingual musculature in obstructive sleep apnea.
J. Appl. Physiol.
81:
643-652,
1996
32.
Schwartz, A. R.,
P. L. Smith,
R. A. Wise,
A. R. Gold,
and
S. Permutt.
Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure.
J. Appl. Physiol.
64:
535-542,
1988
33.
Schwartz, A. R.,
D. Thut,
D. Roach,
E. B. Gauda,
R. A. Wise,
S. Permutt,
and
P. L. Smith.
Effect of CO2 on upper airway pressure-flow relationships: role of neuromuscular activity.
J. Appl. Physiol.
74:
1597-1605,
1993
34.
Schwartz, A. R.,
D. Thut,
D. B. Russ,
M. Seelagy,
D. Roach,
R. G. Brower,
S. Permutt,
R. A. Wise,
and
P. L. Smith.
Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway.
Am. Rev. Respir. Dis.
147:
1144-1150,
1993[Medline].
35.
Shepard, J. W.,
and
S. E. Thawley.
Localization of upper airway collapse during sleep in patients with obstructive sleep apnea.
Am. Rev. Respir. Dis.
141:
1350-1355,
1990[Medline].
36.
Smith, P. L.,
R. A. Wise,
A. R. Gold,
A. R. Schwartz,
and
S. Permutt.
Upper airway pressure-flow relationships in obstructive sleep apnea.
J. Appl. Physiol.
64:
789-795,
1988
37.
Strohl, K. P.,
and
J. M. Fouke.
Dilating forces on the upper airway of anesthetized dogs.
J. Appl. Physiol.
58:
452-458,
1985
38.
Strohl, K. P.,
C. F. O'Cain,
and
A. S. Slutsky.
Alae nasi activity and nasal resistance in healthy subjects.
J. Appl. Physiol.
52:
1432-1437,
1982
39.
Suratt, P. M.,
S. C. Wilhoit,
and
K. Cooper.
Induction of airway collapse with subatmospheric pressure in awake patients with sleep apnea.
J. Appl. Physiol.
57:
140-146,
1984
40.
Tangel, D. J.,
W. S. Mezzanotte,
and
D. P. White.
Influence of sleep on tensor palatini EMG and upper airway resistance in normal man.
J. Appl. Physiol.
70:
2574-2581,
1991
41.
Van de Graff, W. B.,
S. B. Gottfried,
J. Mitra,
E. van Lunteren,
N. S. Cherniack,
and
K. P. Strohl.
Respiratory function of hyoid muscles and hyoid arch.
J. Appl. Physiol.
57:
197-204,
1984
This article has been cited by other articles:
![]() |
K.-Z. Lee, D. D. Fuller, I-J. Lu, L.-C. Ku, and J.-C. Hwang Pulmonary C-fiber receptor activation abolishes uncoupled facial nerve activity from phrenic bursting during positive end-expired pressure in the rat J Appl Physiol, January 1, 2008; 104(1): 119 - 129. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |